Literature DB >> 22217545

HDACs and their inhibitors in immunology: teaching anticancer drugs new tricks.

David P Fairlie, Matthew J Sweet.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22217545     DOI： 10.1038/icb.2011.105

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  3 in total

Review 1.  Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases.

Authors:  Kaustav Das Gupta; Melanie R Shakespear; Abishek Iyer; David P Fairlie; Matthew J Sweet
Journal:  Clin Transl Immunology       Date:  2016-01-29

2.  Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

Authors:  Sophie Bouchat; Nadège Delacourt; Anna Kula; Gilles Darcis; Benoit Van Driessche; Francis Corazza; Jean-Stéphane Gatot; Adeline Melard; Caroline Vanhulle; Kabamba Kabeya; Marion Pardons; Véronique Avettand-Fenoel; Nathan Clumeck; Stéphane De Wit; Olivier Rohr; Christine Rouzioux; Carine Van Lint
Journal:  EMBO Mol Med       Date:  2016-02-01       Impact factor: 12.137

3.  Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.

Authors:  Lei Zhou; Xiran He; Bo Gao; Sidong Xiong
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.